This study aimed to evaluate the prevalence, awareness, and control of hypertension, diabetes, and dyslipidemia in Korea according to sex and age, and to identify factors that were associated with the prevalence, awareness, and control of these cardiovascular risk factors among middle-aged Koreans.A cross-sectional analysis was conducted using 2013 data from the National Health Insurance Service-National Sample Cohort (NHIS-NSC) database. A total of 136,755 individuals were considered eligible based on no history of stroke or heart disease, age of 40 to 64 years at the examination, and completion of health examinations. Data regarding demographic factors and cardiovascular risk factors had been obtained using questionnaires, physical examinations, and blood tests.Hypertension was the most prevalent condition among middle-aged Koreans (25.76%), followed by dyslipidemia (16.58%) and diabetes (10.22%). Among these three conditions, dyslipidemia was associated with the lowest awareness rates (24.14%). Hypertension and diabetes were more prevalent among men than among women, although the prevalence of dyslipidemia was higher among women > 50 years old. The prevalence of hypertension and diabetes increased with advancing age among men and women, although the prevalence of dyslipidemia decreased with age among men (highest prevalence: 50.59% among men aged between 40 and 44 years). Among Korean men (relative to women), the odds ratios were 1.50 for hypertension, 1.96 for diabetes, and 0.82 for dyslipidemia. Age, central obesity, and body mass index were significantly associated with the development of all 3 conditions.There are sex- and age-specific patterns in the prevalence, awareness, and control of hypertension, diabetes, and dyslipidemia in Korea. Dyslipidemia is becoming increasingly common although most middle-aged Koreans are not aware of this condition leading to low control rate. These results may help identify population subgroups at a high risk of hypertension, diabetes, and dyslipidemia, and may guide the management of cardiovascular disease in Korea.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320036 | PMC |
http://dx.doi.org/10.1097/MD.0000000000013713 | DOI Listing |
Ann Transl Med
December 2024
Department of Cardiovascular Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
Background: Patients with end-stage kidney disease (ESKD) are at high risk for coronary artery disease. We investigate the trends and outcomes of percutaneous coronary intervention (PCI) for stable ischemic heart disease (SIHD) in patients with ESKD.
Methods: We utilized the United States Renal Data System [2010-2018] to include adult patients with ESKD on dialysis for at least 3 months who underwent PCI for SIHD.
JACC Adv
December 2024
Johns Hopkins Department of Internal Medicine, Baltimore, Maryland, USA.
Background: Despite implementation of preventive interventions targeting cardiovascular disease (CVD), atherosclerotic CVD (ASCVD) remains a major public health concern in the South Asian (SA) population.
Objectives: The purpose of this study was to assess the risk factor prevalence and ASCVD outcomes in SA population in the United States.
Methods: The DIL Wellness and Arterial health Longitudinal Evaluation registry collected data retrospectively on SA adult patients receiving care in the Baylor Scott & White Healthcare system.
JACC Adv
December 2024
Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, New York, USA.
Background: The Hispanic/Latino population is not uniform. Prevalence and clinical outcomes of cardiac arrhythmias in ethnic background subgroups are variable, but the reasons for differences are unclear. Vectorcardiographic Global Electrical Heterogeneity (GEH) has been shown to be associated with adverse cardiovascular outcomes.
View Article and Find Full Text PDFJACC Adv
December 2024
Alliance for Medical Research in Africa, Dakar, Senegal.
This proposed scientific statement is focused on providing new insights regarding challenges and opportunities for cardiovascular health (CVH) promotion in Africa. The statement includes an overview of the current state of CVH in Africa, with a particular interest in the cardiometabolic risk factors and their evaluation through metrics. The statement also explains the main principles of primordial prevention, its relevance in reducing noncommunicable disease and the different strategies that have been effective worldwide.
View Article and Find Full Text PDFASIDE Intern Med
December 2024
Montefiore-Einstein Cerebrovascular Research Lab, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
Introduction: Managing idiopathic intracranial hypertension (IIH) is challenging due to limited treatment options. This study evaluates metformin as a potential therapy for IIH, examining its impact on disease outcomes and safety.
Methods: We performed a retrospective cohort study using the TriNetX database, covering data from 2009 to August 2024.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!